|
1
|
Harris PS, Hansen RM, Gray ME, Massoud OI,
McGuire BM and Shoreibah MG: Hepatocellular carcinoma surveillance:
An evidence-based approach. World J Gastroenterol. 25:1550–1559.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bou-Nader M, Caruso S, Donne R,
Celton-Morizur S, Calderaro J, Gentric G, Cadoux M, L'Hermitte A,
Klein C, Guilbert T, et al: Polyploidy spectrum: A new marker in
HCC classification. Gut. (pii): gutjnl-2018-318021. 2019.(Epub
ahead of print). PubMed/NCBI
|
|
3
|
Kim HL, An J, Park JA, Park SH, Lim YS and
Lee EK: Magnetic resonance imaging is cost-effective for
hepatocellular carcinoma surveillance in high-risk patients with
cirrhosis. Hepatology. 69:1599–1613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Z, Zou R, Zheng Y, Qiu J, Shen J,
Liao Y, Zhang Y, Wang C, Wang Y, Yuan Y, et al: Lipiodol deposition
in portal vein tumour thrombus predicts treatment outcome in HCC
patients after transarterial chemoembolisation. Eur Radiol.
29:5752–5762. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Al-Zoughbi W, Huang J, Paramasivan GS,
Till H, Pichler M, Guertl-Lackner B and Hoefler G: Tumor
macroenvironment and metabolism. Semin Oncol. 41:281–195. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu T and Dai Y: Tumor microenvironment and
therapeutic response. Cancer Lett. 387:61–68. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirata E and Sahai E: Tumor
microenvironment and differential responses to therapy. Cold Spring
Harb Perspect Med. 7:a0267812017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Q, Ma L, Shen S, Guo Y, Cao Q, Cai X,
Feng J, Yan Y, Hu T, Luo S, et al: Intestinal
dysbacteriosis-induced IL-25 promotes development of HCC via
alternative activation of macrophages in tumor microenvironment. J
Exp Clin Cancer Res. 38:3032019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Francis JM, Kiezun A, Ramos AH, Serra S,
Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis
A, et al: Somatic mutation of CDKN1B in small intestine
neuroendocrine tumors. Nat Genet. 45:1483–1486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang HJ, Oh JH, Chun SM, Kim D, Ryu YM,
Hwang HS, Kim SY, An J, Cho EJ, Lee H, et al: Immunogenomic
landscape of hepatocellular carcinoma with immune cell stroma and
EBV-positive tumor-infiltrating lymphocytes. J Hepatol. 71:91–103.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan Q, Hou S, Zhai J, Tian T, Wu Y, Wu Z,
He J, Chen Z and Zhang J: S100A4 promotes inflammation but
suppresses lipid accumulation via the STAT3 pathway in chronic
ethanol-induced fatty liver. J Mol Med (Berl). 97:1399–1412. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt-Hansen B, Ornås D, Grigorian M,
Klingelhöfer J, Tulchinsky E, Lukanidin E and Ambartsumian N:
Extracellular S100A4(mts1) stimulates invasive growth of mouse
endothelial cells and modulates MMP-13 matrix metalloproteinase
activity. Oncogene. 23:5487–5495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grum-Schwensen B, Klingelhöfer J,
Grigorian M, Almholt K, Nielsen BS, Lukanidin E and Ambartsumian N:
Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a
T-cell deficiency in primary tumors. Cancer Res. 70:936–947. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ringelhan M, Pfister D, O'Connor T,
Pikarsky E and Heikenwalder M: The immunology of hepatocellular
carcinoma. Nat Immunol. 19:222–232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hwang B, Lee JH and Bang D: Single-cell
RNA sequencing technologies and bioinformatics pipelines. Exp Mol
Med. 50:962018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y,
Guo X, Kang B, Hu R, Huang JY, Zhang Q, et al: Landscape of
infiltrating t cells in liver cancer revealed by single-cell
sequencing. Cell. 169:1342–1356 e16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sia D, Jiao Y, Martinez-Quetglas I, Kuchuk
O, Villacorta-Martin C, Castro de Moura M, Putra J, Camprecios G,
Bassaganyas L, Akers N, et al: Identification of an immune-specific
class of hepatocellular carcinoma, based on molecular features.
Gastroenterology. 153:812–826. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhong DN, Ning QY, Wu JZ, Zang N, Wu JL,
Hu DF, Luo SY, Huang AC, Li LL and Li GJ: Comparative proteomic
profiles indicating genetic factors may involve in hepatocellular
carcinoma familial aggregation. Cancer Sci. 103:1833–1838. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng H, Pomyen Y, Hernandez MO, Li C,
Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, et al:
Single-cell analysis reveals cancer stem cell heterogeneity in
hepatocellular carcinoma. Hepatology. 68:127–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Neal JT, Li X, Zhu J, Giangarra V,
Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, et
al: Organoid modeling of the tumor immune microenvironment. Cell.
175:1972–1988 e16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee KH and Kim JR: Regulation of
HGF-mediated cell proliferation and invasion through NF-κB, JunB,
and MMP-9 cascades in stomach cancer cells. Clin Exp Metastasis.
29:263–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Fan J, Francis JM, Georghiou G,
Hergert S, Li S, Gambe R, Zhou CW, Yang C, Xiao S, et al:
Integrated single-cell genetic and transcriptional analysis
suggests novel drivers of chronic lymphocytic leukemia. Genome Res.
27:1300–1311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:ppl12013. View Article : Google Scholar
|
|
26
|
Fishilevich S, Nudel R, Rappaport N, Hadar
R, Plaschkes I, Iny Stein T, Rosen N, Kohn A, Twik M, Safran M, et
al: GeneHancer: Genome-wide integration of enhancers and target
genes in GeneCards. Database (Oxford). 2017. View Article : Google Scholar
|
|
27
|
Fennemann FL, de Vries IJM, Figdor CG and
Verdoes M: Attacking tumors from all sides: Personalized multiplex
vaccines to tackle intratumor heterogeneity. Front Immunol.
10:8242019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ali M, Khan SY, Vasanth S, Ahmed MR, Chen
R, Na CH, Thomson JJ, Qiu C, Gottsch JD and Riazuddin SA:
Generation and proteome profiling of pbmc-originated, ipsc-derived
corneal endothelial cells. Invest Ophthalmol Vis Sci. 59:2437–2444.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van der Wijst MGP, Brugge H, de Vries DH,
Deelen P, Swertz MA; LifeLines Cohort Study BIOS Consortium, ;
Franke L: Single-cell RNA sequencing identifies celltype-specific
cis-eQTLs and co-expression QTLs. Nat Genet. 50:493–497. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song Q, Hawkins GA, Wudel L, Chou PC,
Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, et
al: Dissecting intratumoral myeloid cell plasticity by single cell
RNA-seq. Cancer Med. 8:3072–3085. 2019.PubMed/NCBI
|
|
31
|
Guo C, Liu QG, Zhang L, Song T and Yang X:
Expression and clinical significance of p53, JunB and KAI1/CD82 in
human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
8:389–396. 2009.PubMed/NCBI
|
|
32
|
Guo C, Liu Q, Zhang L, Yang X, Song T and
Yao Y: Double lethal effects of fusion gene of wild-type p53 and
JunB on hepatocellular carcinoma cells. J Huazhong Univ Sci
Technolog Med Sci. 32:663–668. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang YS, Yeh KT, Yang MY, Liu TC, Lin SF,
Chan WL and Chang JG: Abnormal expression of JUNB gene in
hepatocellular carcinoma. Oncol Rep. 13:433–438. 2005.PubMed/NCBI
|
|
34
|
Zhai X, Zhu H, Wang W, Zhang S, Zhang Y
and Mao G: Abnormal expression of EMT-related proteins, S100A4,
vimentin and E-cadherin, is correlated with clinicopathological
features and prognosis in HCC. Med Oncol. 31:9702014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dukhanina EA, Lukyanova TI, Romanova EA,
Guerriero V, Gnuchev NV, Georgiev GP, Yashin DV and Sashchenko LP:
A new role for PGRP-S (Tag7) in immune defense: Lymphocyte
migration is induced by a chemoattractant complex of Tag7 with
Mts1. Cell Cycle. 14:3635–3643. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu J, Ma S, Hotz-Wagenblatt A, Angel P,
Mohr K, Schlimbach T, Schmitt M and Cui G: Regulatory T cells sense
effector T-cell activation through synchronized JunB expression.
FEBS Lett. 593:1020–1029. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim VM, Blair AB, Lauer P, Foley K, Che X,
Soares K, Xia T, Muth ST, Kleponis J, Armstrong TD, et al:
Anti-pancreatic tumor efficacy of a listeria-based, annexin
A2-targeting immunotherapy in combination with anti-PD-1
antibodies. J Immunother Cancer. 7:1322019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nagasawa M, Akasaka Y, Ide T, Hara T,
Kobayashi N, Utsumi M and Murakami K: Highly sensitive upregulation
of apolipoprotein A-IV by peroxisome proliferator-activated
receptor alpha (PPARalpha) agonist in human hepatoma cells. Biochem
Pharmacol. 74:1738–1746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harris WP, Wong KM, Saha S, Dika IE and
Abou-Alfa GK: Biomarker-driven and molecular targeted therapies for
hepatobiliary cancers. Semin Oncol. 45:116–123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ballester M, Revilla M, Puig-Oliveras A,
Marchesi JA, Castelló A, Corominas J, Fernández AI and Folch JM:
Analysis of the porcine APOA2 gene expression in liver,
polymorphism identification and association with fatty acid
composition traits. Anim Genet. 47:552–559. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thulin P, Glinghammar B, Skogsberg J,
Lundell K and Ehrenborg E: PPARdelta increases expression of the
human apolipoprotein A-II gene in human liver cells. Int J Mol Med.
21:819–824. 2008.PubMed/NCBI
|
|
42
|
Lu G, Zhang G, Zheng X, Zeng Y, Xu Z, Zeng
W and Wang K: c9, t11- conjugated linoleic acid induces HCC cell
apoptosis and correlation with PPAR-γ signaling pathway. Am J
Transl Res. 7:2752–2763. 2015.PubMed/NCBI
|
|
43
|
Kahraman DC, Kahraman T and Cetin-Atalay
R: Targeting PI3K/Akt/mTOR pathway identifies differential
expression and functional role of IL-8 in liver cancer stem cell
enrichment. Mol Cancer Ther. 18:2146–2157. 2019.PubMed/NCBI
|
|
44
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006. View Article : Google Scholar : PubMed/NCBI
|
